MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways
about
miRNA biogenesis: biological impact in the development of cancerHypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model.MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.miRNAs in acute myeloid leukemia.Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia.The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.Expression of a passenger miR-9* predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age.A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia.MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.MiRNA Dysregulation in Childhood Hematological Cancer
P2860
Q26824263-58CCB397-FAB0-453F-9274-31EE5576AA1EQ33729914-228F2EC1-EE60-430A-A70A-AC10241792BDQ33749684-7D58D49D-A830-422A-8175-AD4A016FD0B4Q33779361-6CE72D0C-FBB2-410E-BC83-B2C628D2E686Q33872395-F50E0CAB-05E6-425C-B7C4-14CC5DF6674EQ35172553-A366DC78-9E03-4620-B30C-325F61DDC71BQ35543478-222E9253-BB19-476F-8D4E-DFAD325FE0EAQ36413478-D0F962DD-45CE-4187-9DB1-9A9CBB330D98Q36882358-34B85D80-FB59-4F59-B49A-B4B1A6BD67FBQ37709531-EC064AF4-DAE7-4835-887A-740E77C45CF9Q39285462-F45A757C-E99C-4ED7-AC18-3D5330597842Q39496128-97E3D457-B072-40DA-9241-4D2D5604D831Q41225296-E0BB2DA2-2D63-4EFF-8102-169FB13AD25EQ41751946-F2A05DB1-DA25-4220-900D-061B366E859FQ46802244-938B0C28-195E-4641-B839-FE7DA64DAD20Q48104779-44A091B0-3726-46C1-898C-5267A4F5471DQ58753107-118688CE-D1D6-4091-BB33-22ED5A03DD00
P2860
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@ast
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@en
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@nl
type
label
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@ast
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@en
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@nl
prefLabel
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@ast
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@en
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@nl
P2093
P2860
P1433
P1476
MicroRNAs distinguish cytogene ...... works in AML-relevant pathways
@en
P2093
Anamika Giri
Andrea Teigler-Schlegel
Arndt Borkhardt
Gunter Meister
Jutta Bradtke
Pablo Landgraf
Silja Röttgers
Svenja Daschkey
P2860
P304
P356
10.1371/JOURNAL.PONE.0056334
P407
P577
2013-01-01T00:00:00Z